Literature DB >> 18669593

Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein.

Wan-Yee Tang1, Retha Newbold, Katerina Mardilovich, Wendy Jefferson, Robert Y S Cheng, Mario Medvedovic, Shuk-Mei Ho.   

Abstract

Neonatal exposure of CD-1 mice to diethylstilbestrol (DES) or genistein (GEN) induces uterine adenocarcinoma in aging animals. Uterine carcinogenesis in this model is ovarian dependent because its evolution is blocked by prepubertal ovariectomy. This study seeks to discover novel uterine genes whose expression is altered by such early endocrine disruption via an epigenetic mechanism. Neonatal mice were treated with 1 or 1000 microg/kg DES, 50 mg/kg GEN, or oil (control) on d 1-5. One group of treated mice was killed before puberty on d 19. Others were ovariectomized or left intact, and killed at 6 and 18 months of age. Methylation-sensitive restriction fingerprinting was performed to identify differentially methylated sequences associated with neonatal exposure to DES/GEN. Among 14 candidates, nucleosomal binding protein 1 (Nsbp1), the gene for a nucleosome-core-particle binding protein, was selected for further study because of its central role in chromatin remodeling. In uteri of immature control mice, Nsbp1 promoter CpG island (CGI) was minimally methylated. Once control mice reached puberty, the Nsbp1 CGI became hypermethylated, and gene expression declined further. In contrast, in neonatal DES/GEN-treated mice, the Nsbp1 CGI stayed anomalously hypomethylated, and the gene exhibited persistent overexpression throughout life. However, if neonatal DES/GEN-treated mice were ovariectomized before puberty, the CGI remained minimally to moderately methylated, and gene expression was subdued except in the group treated with 1000 microg/kg DES. Thus, the life reprogramming of uterine Nsbp1 expression by neonatal DES/GEN exposure appears to be mediated by an epigenetic mechanism that interacts with ovarian hormones in adulthood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18669593      PMCID: PMC2613067          DOI: 10.1210/en.2008-0682

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  53 in total

1.  Targeting of high mobility group-14/-17 proteins in chromatin is independent of DNA sequence.

Authors:  H Shirakawa; J E Herrera; M Bustin; Y Postnikov
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

Review 2.  HMGN dynamics and chromatin function.

Authors:  Frédéric Catez; Jae-Hwan Lim; Robert Hock; Yuri V Postnikov; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2003-06       Impact factor: 3.626

3.  Expression of c-kit (CD117) in benign and malignant human endometrial epithelium.

Authors:  L W Elmore; K Domson; J R Moore; M Kornstein; R T Burks
Journal:  Arch Pathol Lab Med       Date:  2001-01       Impact factor: 5.534

4.  Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).

Authors:  Julie R Palmer; Elizabeth E Hatch; Carol L Rosenberg; Patricia Hartge; Raymond H Kaufman; Linda Titus-Ernstoff; Kenneth L Noller; Arthur L Herbst; R Sowmya Rao; Rebecca Troisi; Theodore Colton; Robert N Hoover
Journal:  Cancer Causes Control       Date:  2002-10       Impact factor: 2.506

Review 5.  Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals.

Authors:  Barbara Hammes; Cynthia J Laitman
Journal:  J Midwifery Womens Health       Date:  2003 Jan-Feb       Impact factor: 2.388

6.  Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus.

Authors:  Shuanfang Li; Roberta Hansman; Retha Newbold; Barbara Davis; John A McLachlan; J Carl Barrett
Journal:  Mol Carcinog       Date:  2003-10       Impact factor: 4.784

7.  Immunohistochemical evaluation of the c-kit proto-oncogene in sarcomas of the uterus: a case series.

Authors:  Charles A Leath; J Michael Straughn; Michael G Conner; Mack N Barnes; Ronald D Alvarez; Edward E Partridge; Warner K Huh
Journal:  J Reprod Med       Date:  2004-02       Impact factor: 0.142

8.  PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model.

Authors:  Mengchu Wu; Shuk-Mei Ho
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

9.  Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis.

Authors:  Xuegong Zhu; Irwin Leav; Yuet-Kin Leung; Mengchu Wu; Qin Liu; Ying Gao; John E McNeal; Shuk-Mei Ho
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

10.  Id-2 regulates critical aspects of human cytotrophoblast differentiation, invasion and migration.

Authors:  M J Janatpour; M T McMaster; O Genbacev; Y Zhou; J Dong; J C Cross; M A Israel; S J Fisher
Journal:  Development       Date:  2000-02       Impact factor: 6.868

View more
  72 in total

1.  Developmental exposure to endocrine-disrupting chemicals programs for reproductive tract alterations and obesity later in life.

Authors:  Retha R Newbold
Journal:  Am J Clin Nutr       Date:  2011-11-16       Impact factor: 7.045

2.  Epigenetics: A New Bridge between Nutrition and Health.

Authors:  Sang-Woon Choi; Simonetta Friso
Journal:  Adv Nutr       Date:  2010-11-16       Impact factor: 8.701

Review 3.  Applied Healthspan engineering.

Authors:  James W Larrick; Andrew Mendelsohn
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

Review 4.  Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective.

Authors:  Aparna Mahakali Zama; Mehmet Uzumcu
Journal:  Front Neuroendocrinol       Date:  2010-07-04       Impact factor: 8.606

5.  The expression and clinical significance of high mobility group nucleosome binding domain 5 in human osteosarcoma.

Authors:  Xuhui Zhou; Bo Yuan; Wen Yuan; Ce Wang; Rui Gao; Junyan Wang
Journal:  Tumour Biol       Date:  2014-04-02

Review 6.  Steroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic Dysfunctions.

Authors:  Rodolfo C Cardoso; Muraly Puttabyatappa; Vasantha Padmanabhan
Journal:  Neuroendocrinology       Date:  2015-04-01       Impact factor: 4.914

7.  Estrogen imprinting: when your epigenetic memories come back to haunt you.

Authors:  Gail S Prins
Journal:  Endocrinology       Date:  2008-12       Impact factor: 4.736

Review 8.  Environmental epigenetics and its implication on disease risk and health outcomes.

Authors:  Shuk-Mei Ho; Abby Johnson; Pheruza Tarapore; Vinothini Janakiram; Xiang Zhang; Yuet-Kin Leung
Journal:  ILAR J       Date:  2012

Review 9.  HMGNs, DNA repair and cancer.

Authors:  Gabi Gerlitz
Journal:  Biochim Biophys Acta       Date:  2009-12-08

10.  Soy-based Infant Formula Feeding and Heavy Menstrual Bleeding Among Young African American Women.

Authors:  Kristen Upson; Quaker E Harmon; Shannon K Laughlin-Tommaso; David M Umbach; Donna D Baird
Journal:  Epidemiology       Date:  2016-09       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.